NM_001164484.2:c.749C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001164484.2(FAM170B):c.749C>T(p.Ala250Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000574 in 1,551,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164484.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM170B | ENST00000311787.6 | c.749C>T | p.Ala250Val | missense_variant | Exon 2 of 2 | 1 | NM_001164484.2 | ENSP00000308292.6 | ||
FAM170B-AS1 | ENST00000435809.1 | n.192-4161G>A | intron_variant | Intron 1 of 2 | 3 | |||||
FAM170B-AS1 | ENST00000442525.5 | n.439-3940G>A | intron_variant | Intron 1 of 5 | 2 | |||||
FAM170B-AS1 | ENST00000443389.5 | n.433+9440G>A | intron_variant | Intron 1 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000512 AC: 8AN: 156354Hom.: 0 AF XY: 0.0000724 AC XY: 6AN XY: 82872
GnomAD4 exome AF: 0.0000264 AC: 37AN: 1399394Hom.: 0 Cov.: 33 AF XY: 0.0000246 AC XY: 17AN XY: 690196
GnomAD4 genome AF: 0.000341 AC: 52AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.749C>T (p.A250V) alteration is located in exon 2 (coding exon 2) of the FAM170B gene. This alteration results from a C to T substitution at nucleotide position 749, causing the alanine (A) at amino acid position 250 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at